Quick Answer
ONCOLYTICS BIOTECH INC reported Total Assets of $7.58 million for fiscal year 2025.
ONCOLYTICS BIOTECH INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.58M | -43.5% |
| 2024 | $13.42M | -65.4% |
| 2023 | $38.82M | +4.0% |
| 2022 | $37.33M | -18.6% |
| 2021 | $45.88M | +33.6% |
| 2020 | $34.35M | +74.7% |
| 2019 | $19.66M | +32.2% |
| 2018 | $14.87M | -18.1% |
| 2017 | $18.15M | +23.0% |
| 2016 | $14.76M | — |
- ONCOLYTICS BIOTECH INC showed a decrease of -43.5% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, ONCOLYTICS BIOTECH INC’s total assets has declined by 48.6% (from $14.76 million to $7.58 million).
- The most recent figure is from ONCOLYTICS BIOTECH INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: